Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:44 PM
Ignite Modification Date:
2025-12-26 @ 10:44 PM
NCT ID:
NCT01829412
Eligibility Criteria:
Inclusion Criteria:•
.Age ≥18 years , \< 80 years
* Stage I-III (Durie-Salmon) symptomatic MM at the start of first-line treatment or at relapse after disease response (CR or PR) lasting at least 6 months
* Stage I (Durie-Salmon) asymptomatic MM at diagnosis not requiring treatment (substudy for assessment of exploratory objectives)
* Written informed consent
Exclusion Criteria:
* Pregnancy or lactation
* Active secondary malignancy
* Type I hypersensitivity or anaphylactic reactions to Gadolinum contrast agent
* Mental disorders including claustrophobia (ICD 10, F40.2)
* Electronically, magnetically and mechanically activated implants
* Ferromagnetic or electrically operated active devices like automatic cardioverter defibrillators
* Cardiac pacemakers
* Metallic splinters in the eye
* Ferromagnetic haemostatic clips in the central nervous system (CNS) or in the body
* Cochlear implants or stapedial implants
* Insulin pumps and nerve stimulators
* Prosthetic hearth valves
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01829412
Study Brief:
Protocol Section:
NCT01829412